ID: ALA156658

Max Phase: Preclinical

Molecular Formula: C19H22O5

Molecular Weight: 330.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(CCc2cccc(OC)c(=O)c2)cc(OC)c1OC

Standard InChI:  InChI=1S/C19H22O5/c1-21-16-7-5-6-13(10-15(16)20)8-9-14-11-17(22-2)19(24-4)18(12-14)23-3/h5-7,10-12H,8-9H2,1-4H3

Standard InChI Key:  PRYCTZPJGHQBNV-UHFFFAOYSA-N

Associated Targets(non-human)

Tubulin beta chain 424 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.38Molecular Weight (Monoisotopic): 330.1467AlogP: 2.87#Rotatable Bonds: 7
Polar Surface Area: 53.99Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.99CX LogD: 2.99
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: 0.31

References

1. Andres C, Bernardo J, Yan Q, Hastie S, Macdonald T.  (1993)  Combretatroponeshybrids of combretastatin and colchicine. Synthesis and biochemical evaluation,  (4): [10.1016/S0960-894X(01)81230-0]

Source